Our letter aims to discuss the possible mechanisms underlying this finding and understand whether decreased expression of OAS1 might be linked to presence and persistence of anosmia in patients affected from COVID-19-related smell alteration.
OAS1 gene, spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease? / Di Stadio, A.; Bernitsas, E.; Ralli, M.; Severini, C.; Brenner, M. J.; Angelini, C.. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 26:2(2022), pp. 347-349. [10.26355/eurrev_202201_27858]
OAS1 gene, spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease?
Di Stadio A.
Primo
;Ralli M.;
2022
Abstract
Our letter aims to discuss the possible mechanisms underlying this finding and understand whether decreased expression of OAS1 might be linked to presence and persistence of anosmia in patients affected from COVID-19-related smell alteration.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Di Stadio_OAS1 gene_2022.pdf
accesso aperto
Note: https://www.europeanreview.org/article/27858
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
618.98 kB
Formato
Adobe PDF
|
618.98 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
